- Open Access
Assessing developmental toxicity of caffeine and sweeteners in medaka (Oryzias latipes)
© Lee and Wang. 2015
- Received: 16 February 2015
- Accepted: 28 August 2015
- Published: 8 September 2015
The use of artificial sweeteners (ASWs) has increased and become more widespread, and consequently ASWs have appeared in aquatic environments around the world. However, their safety to the health of humans and wildlife remains inconclusive. In this study, using medaka embryos (Oryzias latipes), we investigated developmental toxicity of aspartame (ASP) and saccharin (SAC). Since ASWs are often consumed with caffeine (CAF) and CAF with sucrose (SUC), we tested biological activities of these four substances and the mixtures of CAF with each sweetener. The embryos were exposed to ASP at 0.2 and 1.0 mM, SAC at 0.005 and 0.050 mM, CAF at 0.05 and 0.5 mM, or SUC at 29 and 146 mM, starting from less than 5 h post fertilization until hatch. Control embryos were treated with embryo solution only. Several endpoints were used to evaluate embryonic development. Some of the hatchlings were also tested for anxiety-like behavior with the white preference test. The results showed that all four substances and the mixtures of CAF with the sweeteners affected development. The most sensitive endpoints were the heart rate, eye density, and hatchling body length. The hatchlings of several treatment groups also exhibited anxiety-like behavior. We then used the Integrated Biological Response (IBR) as an index to evaluate the overall developmental toxicity of the substances. We found that the ranking of developmental toxicity was SAC > CAF > ASP > SUC, and there was a cumulative effect when CAF was combined with the sweeteners.
- Developmental toxicity
Artificial sweeteners (ASWs) have been in use for decades, but they are now increasingly added to all kinds of foods, drinks, and pharmaceutical products. As a consequence, ASWs are excreted from our bodies and discharged with sewage treatment effluents to the aquatic environment. Therefore, they have emerged as a class of environmental contaminants.
For example, saccharin (SAC) is largely unmetabolized in human body, allowing it to pass unchanged to the environment, mainly through the urine. It is usually degraded by more than 90 % during wastewater treatment (Lange et al. 2012). However, wastewater is not always properly treated, and SAC concentrations may be too high to be efficiently removed. In a Canadian river watershed, SAC at a concentration of 7.2 µg/L was found where both urban population and the consumption of calorie-reduced beverages were high (Spoelstra et al. 2013). Concentrations of SAC up to 19.7 µg/L were also found from surface waters in Spain (Ordóñez et al. 2012), and up to 137 µg/L from wastewater in Singapore (Tran et al. 2013).
On the other hand, aspartame (ASP) is metabolized to 50 % phenylalanine, 40 % aspartic acid, and 10 % methanol in humans (Ranney et al. 1975). The small amount of methanol has been suggested to be responsible for ASP carcinogenicity (Soffritti et al. 2010). Because these components are absorbed and metabolized as other foods, ASP is usually not detected in environmental water samples (Lange et al. 2012; Ordóñez et al. 2012). Nonetheless, Gan et al. (2013) have reported its presence in surface waters at concentrations up to 0.21 µg/L in China.
Unlike other contaminants, ASWs are substances we actively purchase and ingest regularly, sometimes in large quantities. Although many studies have supported the safety and benefits of ASWs (Weihrauch and Diehl 2004; Marinovich et al. 2013), clear evidence of safety in long-term use is still lacking (Wiebe et al. 2011; Shankar et al. 2013; Gardner 2014). In addition, their developmental toxicity is surprisingly inconclusive. For example, prospective studies on pregnant women have found an association of daily intake of ASWs-containing beverages with preterm delivery (Halldorsson et al. 2010; Englund-Ögge et al. 2012) or offspring allergic diseases (Maslova et al. 2013), but Marinovich et al. (2013) have also concluded in their review study that ASWs were not related to preterm delivery.
Animal studies on developmental toxicity of ASWs are mostly conducted on rats and mice; studies on fish or aquatic organisms are scarce. Saccharin is usually considered safe and often used as a negative control in toxicological studies, such as the study conducted by Selderslaghs et al. (2009). But the authors actually found that saccharin at 55 mM induced 92 % mortality within 24 h post fertilization in zebrafish embryos. As to ASP, Soffritti et al. (2007) have conducted a study with rats using a dose (100 mg/kg bw/day) higher than the acceptable daily intake value for humans (40 mg/kg bw in the European Union and 50 mg/kg bw in the United States). They found that lifespan exposure to the sweetener is carcinogenic, and exposures beginning from prenatal period further increased the risk. Abd Elfatah et al. (2012) also found that a high dose of ASP at 50 mg daily induced histological lesions and genetic alterations in mother rats and their offspring. But an earlier study found no developmental effect from ASP at much higher doses of 500–4000 mg/kg bw (McAnulty et al. 1989).
Due to the need for more information regarding developmental toxicity and ecological impact of ASWs, we used medaka embryos (Oryzias latipes) as a bioassay to tackle both issues at the same time. The fish is an oviparous freshwater teleost. It has become a popular animal model in recent years due to its hardiness, small size (adult 2–4 cm in length), high fecundity (spawn 10–20 eggs daily), and short generational time (2–3 months). Most of all, as medaka embryos are transparent, their development can be easily observed in whole living embryos. These qualities have rendered the fish ideal for developmental toxicity studies.
Here, using medaka embryos, we investigated developmental toxicity of two ASWs, ASP and SAC, along with the natural sweetener sucrose (SUC) and the known developmental toxin-caffeine (CAF). As CAF was often ingested with sweeteners, the combinations of CAF with SUC, ASP, or SAC were tested as well. The concentrations used in this study were much lower than those of the above-mentioned studies because they were intended to be more realistic and environmentally relevant. We also used the white preference test (Lee and Yang 2014) to investigate behavioral consequences of this developmental toxicity. Furthermore, a novel approach—the integrated biomarker response (IBR; Beliaeff and Burgeot 2002; Lee and Lee 2014) was applied to evaluate the overall developmental toxicity of the tested substances.
A colony of medaka had been established in the current facility for over 5 years. They were maintained at 28 °C under a constant 14 h light:10 h dark photoperiod in glass tanks filled with flow-through filtered water (pH 7.5–7.8). Medaka embryos were incubated in embryo solution (0.1 % NaCl, 0.003 % KCl, 0.004 % CaCl2·2H2O, and 0.016 % MgSO4·7H2O, pH 7.5–7.8). All salts in the solution were supplied by J.T.Baker (Phillipsburg, NJ, USA). The fish were fed three times daily with brine shrimp (<24 h after hatching). All procedures were carried out in accordance to the “Guidelines for Animal Experimentation” of Chang Jung Christian University, Taiwan.
Chemicals and test solutions
Abbreviations and concentrations of chemicals used in this study
29,700 mg/kg [Rat]a
>10,000 mg/kg [Rat]c
17,000 mg/kg [Mouse]a
127 mg/kg [Mouse]a
CAF + SUC
CAF2 + SUC1
Refer to individual compounds
CAF + ASP
CAF2 + ASP1
CAF + SAC
CAF2 + SAC1
Medaka embryos from breeding pairs were collected within 5 h post fertilization. They were randomly assigned to different exposure groups, placed in 24-well plates, one embryo per well, and incubated at 27 °C. Each well contained 1 ml embryo or test solutions, which were replaced every 24 h. Embryos treated with embryo solution served as controls. To limit observation period within 2 h, each exposure experiment contained less than 17 embryos (2–4 per group), and the experiment was repeated 13 times. Obviously the 12 treatment groups could not be all tested at the same time, but the control group was always included in each experiment. The embryos were exposed continuously until hatch. The hatchlings were photographed and then transferred to glass dishes containing embryonic solution only.
Observations and image analysis
The procedures were as described previously (Lee et al. 2012). Briefly, the heart rate of embryos was first counted for 1 min under a dissection microscope at 27 °C, then the embryos were anaesthetized with 0.06 % MS222 (pH 7.25, Sigma-Aldrich), and their images recorded under a microscope (IX2-SLP, Olympus, Tokyo, Japan) from 1 to 3 days post fertilization (dpf) and at hatch. The eye length, width, and pigmentation density (eye density), the distance between the eyes (eye distance; representing the head growth), the width of the optic tectum (midbrain width), and the hatchling body length were analyzed from the images with ImageJ image processing and analysis software (http://rsbweb.nih.gov/ij/). All images were obtained and analyzed under identical conditions without any alteration.
White preference test
The white preference test was conducted as described previously (Lee and Yang 2014). Briefly, individual hatchling (4 days after hatching) was held with a pipet for 30 s and then released in the black area of a rectangular box (L 60 mm × W 40 mm × H 15 mm) with two equal black and white areas. A square pattern of 5 × 5 mm2 was drawn on the bottom surface. Once released, hatchlings were allowed to explore freely for 2 min. Each hatchling was tested once. The following endpoints of the hatchling movement were analyzed from the video recording: time lapse to white area, time spent in black or white areas, number of squares entered (indicating swimming distance), and time swimming along the sides or around the center of the box.
The integrated biomarker response (IBR)
The integrated biomarker response (IBR) was calculated as described previously (Beliaeff and Burgeot 2002; Lee and Lee 2014). Briefly, measurements from the treatment groups were standardized as a set of indexes, one set for each endpoint. An IBR value was calculated from the indexes of four endpoints (day to hatch, hatchling body length, time lapse to white area in the behavioral test, and total number of squares hatchlings entered in 60 s) from each treatment group.
The statistics software SPSS 17 (SPSS Inc., Chicago, USA) was used for all data analysis. One-way ANOVA was conducted, followed by the LSD post hoc test to compare variables of each endpoint among the treatment groups. Values were considered as significantly different when P <0.05.
Effects of exposures on embryonic development
Eye width and length
The eye width and length were not affected as much as the heart rate. The eye width of SUC1 increased significantly at 1 and 3 dpf, compared to the control, while that of CAF2 decreased at 2 and 3 dpf (Fig. 2; only data from 3 dpf were shown). However, these differences were small, only up to 6.3 %. A dose dependent effect was found between the pair of CAF1/2 at 3 dpf; CAF2 was 5.1 % smaller than CAF1.
As to the eye length, only ASP1 at 2 dpf (not shown) and SAC2 at 3 dpf (Figs. 1, 2) were significantly shorter than the control. The groups of SAC1/2 also exhibited a dose-dependent effect at 3 dpf: SAC2 was 3.9 % shorter than SAC1.
The exposures did not significantly affect the eye distance until 3 dpf, when SUC2, ASP1, SAC2, CAF2, and CAF2 + SUC1 were significantly shorter than the control (Fig. 2). The differences were also small, only up to 6.9 %. A dose-dependent effect was found between the pairs of SUC1/2 and SAC1/2.
At 1 dpf, the midbrain width of CAF1 and CAF2 increased 14.2 and 10.7 %, respectively, compared to the control (not shown). But this increase disappeared at 2 dpf, and at 3 dpf CAF2 became significantly, though only 3.3 %, shorter than the control (Fig. 2). The midbrain width of SAC2 was also significantly shorter than that of the control at 3 dpf. A dose-dependent effect was found between ASP1/2 at 2 dpf (not shown), and SAC1/2 and CAF1/2 at 3 dpf.
The SAC1 test solution significantly increased (12.9 %) the eye density of the exposed embryos at 3 dpf, compared to the control (Fig. 2). Interestingly, CAF combined with all three sweeteners also raised the eye density significantly; the increases ranged from 12.9 to 27.5 %. A dose-dependent effect was found in SAC1/2; SAC2 averaged 15.2 % lower than SAC1.
Day to hatch
Both SUC1 and SUC2 took 23.9 and 30.0 %, respectively, less time to hatch, compared to the control, but this difference was only statistically significant in SUC2 (Fig. 2). Conversely, the CAF2 + SUC1 and CAF2 + SAC1 groups took 20.3 and 26.8 %, respectively, longer time to hatch than the control, but these differences were not statistically significant.
The groups of SAC2 and CAF1 had significantly lower hatching rates than the control (80.0 ± 11.1 and 71.4 ± 13.0 %, respectively, vs. 100 %). The other groups were comparable to the control (Fig. 2).
Hatchling body length
The hatchlings from SAC2 and CAF2 were 4.3 and 11.4 %, respectively, shorter than the control. Interestingly, the combinations of CAF2 with the sweeteners caused a 7.2–11.7 % significant reduction in hatchling body length, compared to the control. These hatchlings were also significantly shorter than those exposed to SUC1, ASP1, or SAC1 alone (Fig. 2). A dose dependent effect was seen between the pairs of CAF1/2.
Effects of exposures on hatchling anxiety-like behavior
The result showed that, compared to the control (29.1 ± 8.9 s), most of the treatment groups took significantly less time crossing to the white area (Fig. 3a). The differences of this time lapse ranged from 13.0 s (ASP at 16.1 ± 3.6 s, p < 0.05) to 24.3 s (CAF + SUC at 4.8 ± 1.4 s, p < 0.01). At 15 s (Fig. 3b), CAF + SUC and CAF + ASP spent significantly less time in the black area (4.8 ± 1.4 and 5.6 ± 1.5 s, respectively, vs. 10.8 ± 1.7 s, p < 0.05) and more time in the white area. During 15–60 s (Fig. 3c), in addition to CAF + SUC and CAF + ASP, the groups of ASP, SAC, and CAF were also significantly different from the control (p < 0.05) in their time distribution in the black and white areas. During 60–120 s (Fig. 3d), none of the treated groups were significantly different from the control.
As to swimming distance, at 15 s (Fig. 3e), total numbers of squares from CAF + SUC and CAF + ASP were significantly higher than that of the control (10.7 ± 1.2 and 10.1 ± 1.6, respectively, vs. 4.8 ± 1.3, p < 0.05). At 120 s (Fig. 3f), CAF + SUC remained significantly higher than the control (107.0 ± 10.3 vs. 66.3 ± 13.4, p < 0.01), but not CAF + ASP. Interestingly, the hatchlings exposed to CAF + ASP entered significantly more squares than ASP alone (90.8 ± 8.0 vs. 66.0 ± 7.0, p < 0.05), while those exposed to CAF + SUC also entered significantly more squares than SUC or CAF alone (107 ± 10.3 vs. 69.3 ± 7.5 and 66.0 ± 7.0, p < 0.05, respectively).
The cumulative number of squares hatchlings entered during the test period was shown in Fig. 3g, which indicated that CAF + SUC caused the highest increase among the groups. As shown in Fig. 3h, statistical analyses on the slopes of these cumulative curves produced identical results to those in Fig. 3f.
Interestingly, when in the white area, the hatchlings spent 65.3 ± 2.9 % of the time swimming along the sides, but when in the black area they spent 91.6 ± 1.6 % of the time swimming around the center. This phenomenon was consistent with our previous study (Lee and Yang 2014), but there was no significant difference in this side/center preference among the groups. However, a dose dependent effect was found in the pairs of SAC1/2: when in the white area, the SAC2 group spent significantly more time along the sides of the box, compared to SAC1 (70.3 ± 9.6 vs. 49.0 ± 5.8 %, p < 0.05).
Integrated biomarker response (IBR) of the treatment groups
To better assess relative developmental toxicity of the substances, the IBRs of the treatment groups were calculated with four endpoints: day to hatch, hatchling body length, time lapse to white area in the behavioral test, and total number of squares hatchlings entered in 60 s.
Lastly, to explore the possibility of producing a cumulative effect when CAF was combined with the sweeteners, we compared the actual IBRs of the CAF mixtures with the sums of IBRs from each corresponding individual substance groups. It turned out that the values were quite similar, resulting in a ratio averaged 0.93 ± 0.05.
Effects of CAF and the sweeteners on embryonic development
Summary of biological responses in medaka embryos exposed to various substances during development
CAF + SUC
CAF + ASP
CAF + SAC
As expected, CAF affected development in all six categories listed in Table 2. Surprisingly, all the substances and their combinations affected embryonic heart rates (SUC2 significantly increased the heart rate at 2 dpf, not shown in Fig. 2). In addition, the mixtures of CAF with the sweeteners also advanced the eye development, shortened the hatchling body length, and/or modified behavior.
Caffeine has been known to have developmental toxicity in fish. It had no effect at less than 0.75 mM in zebrafish embryos, but at 1 mM or higher it produced hatchlings with shorter body length (Chen et al. 2008), an effect consistent with our results. Also using zebrafish embryos, Hermsen et al. (2013) reported that CAF at 0.22–1.75 mM induced scoliosis and head and heart malformations. Selderslaghs et al. (2009) also found that CAF at 0.1 mM induced higher incidences of deformed tails, but the hatching rate was only slightly affected. In our study, CAF1 (0.05 mM) caused a 29 % decrease in the hatching rate, but not CAF2 at 0.5 mM. In addition, no apparent malformation was observed from both groups. However, CAF2 significantly shortened the eye and midbrain width and hatchling body length, and raised the heart rates. It is likely that species differences contribute to the inconsistencies, and consequences of CAF biological activities vary with different concentrations and endpoints.
Caffeine is a known psychostimulant; it has been found to activate brain activity and cerebral blood flow in humans, and may induce anxiety in higher doses (Chen and Parrish 2009). Nehlig and Debry (1994) also reported that pregnant rats and mice ingested CAF in doses equivalent to tens of cups of coffee per day produced offspring with altered behavior, including learning abilities and anxiety levels. Recently, Silva et al. (2013) demonstrated that female mice exposed to CAF during pregnancy and lactation produced offspring with increased neuronal network excitability, and the offspring grew up to have cognitive deficits.
However, Brent et al. (2011), after reviewing epidemiological and animal studies, have reported that evidence for developmental toxicity of CAF in humans is inconclusive. The authors indicated that the plasma level of CAF has to reach 0.3 mM to cause teratogenic effects. It is a level roughly equivalent to consuming more than 30 cups of coffee a day in humans, a fairly unlikely scenario. This plasma level of 0.3 mM was in-between the concentrations of CAF1 and CAF2 of this study. Since CAF1 at 0.05 mM already produced effects on medaka development, such as increasing the heart rate and inducing anxiety-like behavior (the time lapses of CAF1 and CAF2 hatchlings moving to the white area were both significantly shorter than that of the control), apparently for subtler effects the minimum plasma level of CAF is likely to be lower.
Other than CAF, SAC was another substance affecting all six categories (Table 2). As SAC also induced significant differences at much lower concentrations than SUC and ASP, it is likely to be more toxic than the other two. This is consistent with the result from a study by Bandyopadhyay et al. (2008), in which SAC at lower concentrations induced more DNA damage than ASP did in mouse bone marrow cells.
Though SAC at 55 mM produced 92 % mortality in zebrafish embryos, it caused no effect at concentrations up to 27.9 mM (Selderslaghs et al. 2009). In another study with zebrafish embryos, SAC at 10 mM did not cause any deformity (Hermsen et al. 2013). In the current study, SAC at a much lower concentration of 0.05 mM caused 20 % mortality, suggesting that, compared to zebrafish, medaka embryos were more sensitive to SAC.
Effects of SUC (or glucose) on development have been studied extensively. It is well-known that diabetic mothers are at five-time higher risk of producing offspring with congenital malformation (Chappell et al. 2009). Glucose exposure at 50 and 100 mM induced malformations and higher than 70 % of mortality in cultured chick embryos (Datar and Bhonde 2005), or impaired neuronal development at 25 mM in quail embryos (Chen et al. 2013). Furthermore, preterm infants given repeated high dose of sucrose were more likely to show poorer attention and motor development (Johnston et al. 2002). In this study, SUC at high concentrations (29 and 146 mM) appeared to have a slight effect on medaka development. But it did not significantly affect hatchlings’ white preference behavior, unless combined with CAF, an issue to be discussed in next section.
Interaction of CAF and sweeteners in anxiety-like behavior
Our results suggest that SUC is relatively safe at high concentrations. But when combined with CAF, it surprisingly heightened anxiety-like behavior in hatchlings. Furthermore, the mixture of CAF with ASP also significantly raised the anxiety level.
Caffeine has been known to potentiate the reinforcing effects of alcohol through adenosine and dopamine neurotransmission when the two substances are combined (Ferré and O’Brien 2011). Similarly, CAF has been linked to increased additive properties of other abused substances, including cocaine, nicotine, and sugar (Temple 2009). Incidentally, SUC-dependent rats have been shown to have altered dopamine receptors and opioid mRNA levels similar to those in morphine-dependent rats (Spangler et al. 2004). Thus, our result was consistent with the notion that the interaction between CAF and SUC may pose a health risk to younger populations (Seifert et al. 2011). However, whether this interaction represents a synergistic relationship would require further studies using appropriate mixture designs.
The potential toxicity of ASP has been investigated extensively for decades, and so far ASP is still considered very safe (Butchko et al. 2002). More recent studies also reported no evidence supporting a risk to human health, including preterm deliveries (Marinovich et al. 2013), nervous system function, learning, and behavior (Magnuson et al. 2007). But in our study, ASP increased the heart rate in medaka embryos, slightly suppressed the head growth, and induced anxiety-like behavior in hatchlings. Therefore, more studies are needed to ensure the safety of ASP consumption.
Cumulative effects of CAF and sweeteners
From the IBRs, we found a cumulative effect in developmental toxicity when CAF is combined with the sweeteners. However, further studies are required to confirm the result.
Caffeine is not very soluble in water, due to its non-polar ring structure. Consequently, the molecules tend to self-aggregate and stack with each other on their flat surface like coins (Tavagnacco et al. 2011). In the presence of SUC, CAF would be drawn by a weak affinity to stack with SUC instead, which increases CAF solubility (Lilley et al. 1992). Both ASP and SAC also have ring structures, and they might similarly stack with CAF in solutions. But this is just speculation, and there is no evidence indicating that this structurally stacking contributes to the cumulative effect of CAF with the sweeteners.
The IBR values of the SAC1 and CAF2 groups were the lowest among the groups, while those of ASP and SUC were at the similar level. Since the concentration of SAC1 was much lower than that of CAF2, and that of ASP1/2 was much lower than that of SUC1/2, the ranking of developmental toxicity should be SAC > CAF > ASP > SUC. We have also demonstrated that the IBR is a useful tool to evaluate developmental toxicity with multiple endpoints.
As the concentrations of SAC and ASP tested in this study were at least 10 times higher than those found in the environment, the health risk of these two substances on wildlife may be negligible. However, CAF and other ASWs are increasingly found in aquatic environments. For example, CAF and cyclamate have been found to be at the concentrations of 265–14,418 and 28–1406 ng/L, respectively, in surface water (Tran et al. 2013). Their cumulative activities may amount to significant levels and deserve more investigations.
We used the medaka embryo as a model system to evaluate developmental toxicity of CAF and three sweeteners: SUC, ASP, and SAC. Several endpoints for development were selected for evaluation, including the heart rate, eye density, time to hatch, and anxiety-like behavior. We found that all four substances and the mixtures of CAF with the sweeteners affected development and/or behavior. We then used the IBR to better evaluate the overall toxicity of these substances. The result showed that the ranking of developmental toxicity was SAC > CAF > ASP > SUC, and there was a cumulative effect when CAF was combined with the sweeteners. Although the concentrations we tested were higher than those detected from the environment, this study has demonstrated that ASWs may pose a health risk to both humans and wildlife, and the effects may accumulate to significant levels when CAF is combined with ASWs.
WL and Y-CW designed the study. Y-CW performed the experiment. WL wrote the manuscript. Both authors read and approved the final manuscript.
This work was supported by a Grant (MOST 104-2314-B-309-003) from the Ministry of Science and Technology, Republic of China.
Compliance with ethical guidelines
Competing interests The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Abd Elfatah AA, Ghaly IS, Hanafy SM (2012) Cytotoxic effect of aspartame (diet sweet) on the histological and genetic structures of female albino rats and their offspring. Pak J Biol Sci 15:904–918View ArticleGoogle Scholar
- Bandyopadhyay A, Ghoshal S, Mukherjee A (2008) Genotoxicity testing of low-calorie sweeteners: aspartame, acesulfame-K, and saccharin. Drug Chem Toxicol 31:447–457View ArticleGoogle Scholar
- Beliaeff B, Burgeot T (2002) Integrated biomarker response (IBR): a useful graphical tool for ecological risk assessment. Environ Toxicol Chem 21:1316–1322View ArticleGoogle Scholar
- Brent RL, Christian MS, Diener RM (2011) Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res B Dev Reprod Toxicol 92:152–187View ArticleGoogle Scholar
- Butchko HH, Stargel WW, Comer C, Mayhew DA, Benninger C, Blackburn G, de Sonneville LM, Geha R, Hertelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK (2002) Aspartame: review of safety. Regul Toxicol Pharmacol 35:S1–S93View ArticleGoogle Scholar
- Chappell JH Jr, Wang XD, Loeken MR (2009) Diabetes and apoptosis: neural crest cells and neural tube. Apoptosis 14:1472–1483View ArticleGoogle Scholar
- Chen Y, Parrish TB (2009) Caffeine dose effect on activation-induced BOLD and CBF responses. Neuroimage 46:577–583View ArticleGoogle Scholar
- Chen YH, Huang YH, Wen CC, Wang YH, Chen WL, Chen LC, Tsay HJ (2008) Movement disorder and neuromuscular change in zebrafish embryos after exposure to caffeine. Neurotoxicol Teratol 30:440–447View ArticleGoogle Scholar
- Chen Y, Fan JX, Zhang ZL, Wang G, Cheng X, Chuai M, Lee KK, Yang X (2013) The negative influence of high-glucose ambience on neurogenesis in developing quail embryos. PLoS One 8:e66646View ArticleGoogle Scholar
- Datar S, Bhonde RR (2005) Shell-less chick embryo culture as an alternative in vitro model to investigate glucose-induced malformations in mammalian embryos. Rev Diabet Stud 2:221–227View ArticleGoogle Scholar
- Englund-Ögge L, Brantsæter AL, Haugen M, Sengpiel V, Khatibi A, Myhre R, Myking S, Meltzer HM, Kacerovsky M, Nilsen RM, Jacobsson B (2012) Association between intake of artificially sweetened and sugar-sweetened beverages and preterm delivery: a large prospective cohort study. Am J Clin Nutr 96:552–559View ArticleGoogle Scholar
- Ferré S, O’Brien MC (2011) Alcohol and caffeine: the perfect storm. J Caffeine Res 1:153–162View ArticleGoogle Scholar
- Gan Z, Sun H, Feng B, Wang R, Zhang Y (2013) Occurrence of seven artificial sweeteners in the aquatic environment and precipitation of Tianjin, China. Water Res 47:4928–4937View ArticleGoogle Scholar
- Gardner C (2014) Non-nutritive sweeteners: evidence for benefit vs. risk. Curr Opin Lipidol 25:80–84View ArticleGoogle Scholar
- Halldorsson TI, Strom M, Petersen SB, Olsen SF (2010) Intake of artificially sweetened soft drinks and risk of preterm delivery: a prospective cohort study in 59,334 Danish pregnant women. Am J Clin Nutr 92:626–633View ArticleGoogle Scholar
- Hermsen SA, Pronk TE, van den Brandhof EJ, van der Ven LT, Piersma AH (2013) Transcriptomic analysis in the developing zebrafish embryo after compound exposure: individual gene expression and pathway regulation. Toxicol Appl Pharmacol 272:161–171View ArticleGoogle Scholar
- Johnston CC, Filion F, Snider L, Majnemer A, Limperopoulos C, Walker CD, Veilleux A, Pelausa E, Cake H, Stone S, Sherrard A, Boyer K (2002) Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks’ postconceptional age. Pediatrics 110:523–528View ArticleGoogle Scholar
- Lange FT, Scheurer M, Brauch HJ (2012) Artificial sweeteners—a recently recognized class of emerging environmental contaminants: a review. Anal Bioanal Chem 403:2503–2518View ArticleGoogle Scholar
- Lee W, Lee CC (2014) Developmental toxicity of cigarette butts—an underdeveloped issue. Ecotoxicol Environ Saf 113:362–368View ArticleGoogle Scholar
- Lee W, Yang K-L (2014) Using medaka embryos as a model system to study biological effects of the electromagnetic fields on development and behavior. Ecotoxicol Environ Saf 108:187–194View ArticleGoogle Scholar
- Lee W, Kang CW, Su CK, Okubo K, Nagahama Y (2012) Screening estrogenic activity of environmental contaminants and water samples using a transgenic medaka embryo bioassay. Chemosphere 88:945–952View ArticleGoogle Scholar
- Lilley TH, Linsdell H, Maestre A (1992) Association of caffeine in water and in aqueous solutions of sucrose. J Chem Soc Faraday Trans 88:2865–2870View ArticleGoogle Scholar
- Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM (2007) Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol 37:629–727View ArticleGoogle Scholar
- Marinovich M, Galli CL, Bosetti C, Gallus S, La Vecchia C (2013) Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues. Food Chem Toxicol 60C:109–115View ArticleGoogle Scholar
- Maslova E, Strøm M, Olsen SF, Halldorsson TI (2013) Consumption of artificially-sweetened soft drinks in pregnancy and riskof child asthma and allergic rhinitis. PLoS One 8:e57261View ArticleGoogle Scholar
- McAnulty PA, Collier MJ, Enticot J, Tesh JM, Mayhew DA, Comer CP, Hjelle JJ, Kotsonis FN (1989) Absence of developmental effects in CF-1 mice exposed to aspartame in utero. Fundam Appl Toxicol 13:296–302View ArticleGoogle Scholar
- Nehlig A, Debry G (1994) Consequences on the newborn of chronic maternal consumption of coffee during gestation and lactation: a review. J Am Coll Nutr 13:6–21View ArticleGoogle Scholar
- Ordóñez EY, Quintana JB, Rodil R, Cela R (2012) Determination of artificial sweeteners in water samples by solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A 1256:197–205View ArticleGoogle Scholar
- Ranney RE, Mares SE, Schroeder RE, Hutsell TC, Radzialowski FM (1975) The phenylalanine and tyrosine content of maternal and fetal body fluids from rabbits fed aspartame. Toxicol Appl Pharmacol 32:339–346View ArticleGoogle Scholar
- Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE (2011) Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 127:511–528View ArticleGoogle Scholar
- Selderslaghs IW, Van Rompay AR, De Coen W, Witters HE (2009) Development of a screening assay to identify teratogenic andembryotoxic chemicals using the zebrafish embryo. Reprod Toxicol 28:308–320View ArticleGoogle Scholar
- Shankar P, Ahuja S, Sriram K (2013) Non-nutritive sweeteners: review and update. Nutrition 29:1293–1299View ArticleGoogle Scholar
- Silva CG, Métin C, Fazeli W, Machado NJ, Darmopil S, Launay PS, Ghestem A, Nesa MP, Bassot E, Szabó E, Baqi Y, Müller CE, Tomé AR, Ivanov A, Isbrandt D, Zilberter Y, Cunha RA, Esclapez M, Bernard C (2013) Adenosine receptor antagonists including caffeine alter fetal brain development in mice. Sci Transl Med 5:197ra104View ArticleGoogle Scholar
- Soffritti M, Belpoggi F, Tibaldi E, Esposti DD, Lauriola M (2007) Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ Health Perspect 115:1293–1297View ArticleGoogle Scholar
- Soffritti M, Belpoggi F, Manservigi M, Tibaldi E, Lauriola M, Falcioni L, Bua L (2010) Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice. Am J Ind Med 53:1197–1206View ArticleGoogle Scholar
- Spangler R, Wittkowski KM, Goddard NL, Avena NM, Hoebel BG, Leibowitz SF (2004) Opiate-like effects of sugar on gene expression in reward areas of the rat brain. Mol Brain Res 124:134–142View ArticleGoogle Scholar
- Spoelstra J, Schiff SL, Brown SJ (2013) Artificial sweeteners in a large canadian river reflect human consumption in the watershed. PLoS One 8:e82706View ArticleGoogle Scholar
- Tavagnacco L, Schnupf U, Mason PE, Saboungi M-L, Cesàro A, Brady JW (2011) Molecular dynamics simulation studies of caffeine aggregation in aqueous solution. J Phys Chem B 115:10957–10966View ArticleGoogle Scholar
- Temple JL (2009) Caffeine use in children: what we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev 33:793–806View ArticleGoogle Scholar
- Tran NH, Hu J, Ong SL (2013) Simultaneous determination of PPCPs, EDCs, and artificial sweeteners in environmental water samples using a single-step SPE coupled with HPLC–MS/MS and isotope dilution. Talanta 113:82–92View ArticleGoogle Scholar
- Weihrauch MR, Diehl V (2004) Artificial sweeteners—do they bear a carcinogenic risk? Ann Oncol 15:1460–1465View ArticleGoogle Scholar
- Wiebe N, Padwal R, Field C, Marks S, Jacobs R, Tonelli M (2011) A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes. BMC Med 9:123View ArticleGoogle Scholar